Delivery Order SPE2DR25D3201-SPE2DR26FT6AB
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 28, 2025, for the supply of Scemblix (40 mg tablets) in quantities of 60s, with a ceiling value of $13,973.47 and an ultimate completion date of December 19, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $13,259.50 on November 6, 2025, for the supply of Scemblix 40 mg tablets (60-count units). This is a firm fixed-price, non-set-aside contract with performance completion targeted for December 1, 2025, and will be fulfilled from the vendor's Conshohocken, Pennsylvania location. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical...
- The Defense Logistics Agency awarded a delivery order valued at $13,259.50 to AmerisourceBergen Drug Corp for the supply of Scemblix 40 mg tablets (60-count units) under a firm fixed-price contract. The order, issued on August 22, 2025, with an ultimate completion date of September 15, 2025, represents a competitively awarded, non-set-aside procurement executed through AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The place of performance is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on January 2, 2026, for the supply of Scemblix 40 mg tablets in quantities of 60 units, with a ceiling value of $31,912.66 and a completion date of January 26, 2026. This competitively awarded, firm fixed-price delivery order represents a non-set-aside procurement under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $13,973.47 to supply 60 tablets of Scemblix 40 mg, a pharmaceutical product for federal medical procurement needs. This non-competitive delivery order, issued on December 15, 2025, with completion scheduled for January 7, 2026, was awarded under firm fixed-price terms to AmerisourceBergen's Corporate Office located in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 12, 2025, for the supply of Scemblix 40 mg tablets (60-count units) valued at $27,946.94 with a firm fixed-price arrangement. The award represents a non-competitive delivery order issued under AmerisourceBergen's existing indefinite delivery contract with DLA Troop Support Medical. The place of performance is the contractor's corporate office location in Conshohocken, Pennsylvania, with an ultimate...
- The Defense Logistics Agency awarded a delivery order valued at $47,868.99 to AmerisourceBergen Drug Corp for the supply of Scemblix 40 mg tablets (60-count units) under a firm fixed-price contract. The award, issued on January 16, 2026, with an ultimate completion date of February 9, 2026, represents a competitively awarded, non-set-aside procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor, with parent company Cencora, Inc....
- The Defense Logistics Agency awarded a delivery order valued at $13,259.50 to AmerisourceBergen Drug Corp for 60 units of Scemblix 40 mg tablets, with an ultimate completion date of August 18, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and represents a single transaction under the company's larger pharmaceutical supply relationship with the federal government. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a major...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $13,973.47 to AmerisourceBergen Drug Corp for the supply of Scemblix 40 mg tablets (60-count units). This is a firm fixed-price, non-set-aside contract with a completion date of December 30, 2025, and an award date of December 8, 2025. The pharmaceutical product will be delivered to the company's Conshohocken, Pennsylvania location. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a $13,973.47 firm fixed-price delivery order to AmerisourceBergen Drug Corp on December 22, 2025, for the supply of Scemblix 40 mg tablets (60-count units). This is a non-set-aside competitive award with an ultimate completion date of January 14, 2026. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate headquarters. This delivery order represents a child contract issued under...
- SPE2DR25D3201Indefinite Delivery Contract
- SPE2DR25D3201-SPE2DR26FT6ABDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $15,935.65 to Amerisourcebergen Drug Corp (a subsidiary of Cencora, Inc.) on January 28, 2026, for the supply of Scemblix 20 mg tablets in quantities of 60 units. This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of February 19, 2026. The contract will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a task order issued under Amerisourcebergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999 global pharmaceutical supply agreement running through December 2026 that enables the company to deliver a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. Amerisourcebergen Drug Corp serves as a critical pharmaceutical distributor for federal military and veteran healthcare systems, supplying brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. The company's extensive portfolio of federal contract awards with the Defense Logistics Agency demonstrates its capability to meet competitive procurement requirements for essential pharmaceutical commodities required by military treatment facilities and other federal medical institutions. This specific delivery order for Scemblix, a specialty medication, aligns with the company's established role in providing targeted prescription medications to support federal healthcare needs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $15.9k | 1/27/26 |